REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Acyclic Nitrogen Double Bonded To Acyclic Nitrogen, Acyclic Nitrogen Triple Bonded To Acyclic Nitrogen Or Azide Doai > Acyclic C-n=n-n Containing Acyclic C-n=n-n ContainingAcyclic C-n=n-n Containing patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.02/01/07 - 20070027118 - Novel compounds of amino sulfonyl derivatives T is a (4 to 10)-membered heterocyclyl and wherein R1, R2 and R3 are as defined in the specification. The invention also relates to pharmaceutical compositions comprising the compounds of formula (I) and methods of treating a condition that is mediated by the modulation of the 11-β-hsd-1 enzyme. ... 01/25/07 - 20070021394 - 2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative [wherein R1 and R2 are identical or different, and each represents a hydrogen atom, a C1-10alkyl group or the like; X represents a hydrogen atom or a fluorine atom; Y represents —OCHR3R4 or the like (wherein R3 and R4 are identical or different, and each represents a hydrogen atom, a ... 12/28/06 - 20060293289 - Compounds capable of activating cholinergic receptors The present invention generally relates to nicotinic compounds, in the form of aryl substituted olefinic compounds, as well as pro-drug, N-oxide, metabolite and pharmaceutically acceptable salt forms thereof. Methods of modulating neurotransmitter release via administration of the compounds, pro-drugs, N-oxides and/or pharmaceutically acceptable salts are also disclosed. ... 11/30/06 - 20060270637 - Hydroxymethyl substituted dihydroisoxazole derivatives useful as antibiotic agents Compounds of the formula (I), or a pharmaceutically-acceptable salt, or an in-vivo-hydrolysable ester thereof, (I) R1a is NH(C═W)R5 or (a); W is O or S; R2 and R3 are for example H or F; R1 is for example hydrogen, or halogen; R5 is selected from hydrogen, (2-6C)alkyl (optionally substituted); R6 ... 11/02/06 - 20060247217 - Tricyclic protein kinase inhibitors which are useful as inhibitors of protein tyrosine kinase and are antiproliferative agents. ... 10/19/06 - 20060234987 - Neuroprotective benzo 1 3 oxathiol 2 ones This invention relates to benzo[1,3]oxathiol-2-ones, derivatives, and precursors thereof, and their use as neuroprotective agents in the treatment and prevention of neuronal disorders of the central and peripheral nervous systems. ... 08/31/06 - 20060194772 - Triamide-substituted heterobicyclic compounds wherein R1-R8 are as defined in the specification, as well as pharmaceutical compositions and uses thereof, and processes for preparing the compounds. The compounds of the invention are useful for the treatment of obesity and lipid disorders. ... 07/06/06 - 20060148764 - 5-phenypyrimidines their preparation compositions comprising them and their use in which Ra, Rb and Rc are as defined in the description; X is halogen, alkyl, alkoxy or haloalkyl; and m is an integer from 1 to 5; processes for preparing these compounds, compositions comprising them and their use for controlling harmful fungi are described. ... // - 5-Phenylpyrimidines of the formula I - ... 06/22/06 - 20060135488 - Ptp1b inhibitors This invention relates to modulating (e.g., inhibiting) protein tyrosine phosphatase 1B (PTP1B). ... 06/22/06 - 20060135487 - Piperazine derivatives and their use as anti-inflammatory agents This invention is directed to acyl piperazine derivatives which are useful as anti-inflammatory agents. This invention is also directed to pharmaceutical compositions containing the compounds of the invention, and methods of using the compounds to treat inflammatory disorders in humans. ... 06/22/06 - 20060135486 - Use of sulfonamide-including compounds in combination with angiogenesis inhibitors The present invention relates to pharmaceutical compositions comprising a sulfonamide-including compound in combination with an angiogenesis inhibitor. ... 06/15/06 - 20060128674 - Intermediates for imidazonaphthyridines Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are disclosed. ... 04/06/06 - 20060074056 - Inhibitors of vegf receptor and hgf receptor signaling The invention relates to the inhibition of VEGF receptor signaling and HGF receptor signaling. The invention provides compounds and methods for inhibiting VEGF receptor signaling and HGF receptor signaling. The invention also provides compositions and methods for treating cell proliferative diseases and conditions ... 01/26/06 - 20060019932 - Treatment of rheumatoid arthritis by inhibition of pde4 A method of treatment of rheumatoid arthritis administers an effective amount of a compound that inhibits phospho-diesterase-4. ... 12/29/05 - 20050288261 - Compositions and method for treating infection in cattle and swine Novel formulations combining a non-steroidal anti-inflammatory drug (NSAID) such as flunixin, with a fluorinated chioramphenicol or thiamphenicol derivative antibiotic such as florfenicol are disclosed. Methods for using such formulations in the treatment and prevention of infectious diseases of bovines and swine, including bovine respiratory disease and swine respiratory disease, are ... 07/14/05 - 20050153942 - Heterocyclic inhibitors of mek and methods of use thereof and pharmaceutically acceptable salts and prodrugs thereof, wherein R1, R2, R7, R8 and R9, W, X, Y and Z are as defined in the specification. Such compounds are MEK inhibitors and are useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals, and inflammatory conditions. Also ... 06/23/05 - 20050137173 - Bicyclic cannabinoid agonists for the cannabinoid receptor Novel polycyclic cannabinoid analogs are presented which have preferentially high affinities for the cannabinoid CB2 receptor sites. The improved receptor affinity makes these analogs therapeutically useful as medications in individuals and animals for treatment of pain, glaucoma, epilepsy, nausea associated with chemotherapy. ... 06/16/05 - 20050130943 - Bicyclic inhibitors of mek and methods of use thereof and pharmaceutically acceptable salts and prodrugs thereof, wherein R1, R2, R7, R8, R9, R10, R20, R21, and R22 are as defined in the specification. Such compounds are MEK inhibitors and useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals, and inflammatory conditions. Also disclosed are ... 06/02/05 - 20050119234 - Cannabimimetic indole derivatives Cannabimimetic indole derivatives are presented which have preferentially high affinities for one of the cannabinoid CB1 or CB2 receptor sites. The improved receptor affinity makes these analogs therapeutically useful as medications in individuals and animals. ... ### FreshPatents.com Support |